Policy and Legislation
The Centers for Medicare & Medicaid Services has added 89 more accountable care organizations (ACOs) to coordinate care and improve quality for Medicare patients in 40 states and Washington, D.C.
On Friday, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that would update many payment policies and rates involving services for Medicare beneficiaries in hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs) beginning on Jan. 1. 2013.
The Centers for Medicare & Medicaid Services (CMS) is sending some sunshine in the direction of primary care providers. In a proposed rule issued July 6, CMS is offering payment increases for family physicians and other primary care providers as well as proposals to better pay for the range of care primary care providers give patients.
Some standard political campaign ploys are not going to cut it this campaign season say campaign watchers -- at least when coupled with the issue of healthcare.
CMS fears seniors may not be taking advantage of the information available to them because the process is too complex to navigate.
The Food and Drug Administration (FDA) released a proposed rule that most medical devices distributed in the United States carry a unique device identifier (UDI).
The Department of Health and Human Services (HHS) has awarded more than $971 million to continue improving preparedness and health outcomes for a wide range of public health threats within every state, eight U.S. territories and four of the nation's largest metropolitan areas, HHS officials announced Monday.
A new tracking poll conducted by Kaiser Family Foundation in the wake of the Supreme Court ruling on the Affordable Care Act showed that slightly more Americans approved of the decision with 47 percent voicing approval and 43 percent disapproving.
Large pharmaceutical company GlaxoSmithKline (GSK) has agreed to pay $3 billion in order to resolve charges of engaging in illegal schemes related to unlawful marketing and pricing of some of the drugs it manufactures in what has become the largest healthcare fraud scheme in the country's history.
As part of the ACA, the Supreme Court upheld a new tax provision intended to help fund healthcare reform -- a 2.3 percent excise tax on medical device sales beginning Jan. 1, 2013.